HOSPITAL UNIVERSITARIO RUBER
Departamento
New York University School of Medicine
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de New York University School of Medicine (10)
2022
2021
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2019
-
Assessment of Quality of Life and Treatment Outcomes of Patients with Persistent Postchemotherapy Alopecia
JAMA Dermatology, Vol. 155, Núm. 6, pp. 724-728
-
Hair disorders in cancer survivors
Journal of the American Academy of Dermatology, Vol. 80, Núm. 5, pp. 1199-1213
-
Hair disorders in patients with cancer
Journal of the American Academy of Dermatology, Vol. 80, Núm. 5, pp. 1179-1196
-
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: Cohort A of the phase II KEYNOTE-086 study
Annals of Oncology, Vol. 30, Núm. 3, pp. 397-404
-
Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
Breast Cancer Research and Treatment, Vol. 174, Núm. 1, pp. 15-26
2018
-
Endocrine therapy-induced alopecia in patients with breast cancer
JAMA Dermatology, Vol. 154, Núm. 6, pp. 670-675
2017
-
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
Oncogene, Vol. 36, Núm. 19, pp. 2737-2749
2015
-
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Nature Genetics, Vol. 47, Núm. 3, pp. 250-256